A new course of action:
Developing a cell-based solution to hair loss

RepliCel Life Sciences Inc. is developing a scientific technology that has the potential to become the world's first, minimally invasive, permanent solution for hair loss in men and women.

Using autologous cell implantation technology, dermal sheath cup cells are taken from a subject's own healthy hair follicles and are replicated into the millions over a three month period. These cells are reintroduced into areas of hair loss and the anticipated result is the development of new hair follicles. The procedure has been in development over the past nine years by the company's research scientists and medical experts, and is currently undergoing phase I/IIa clinical trials in Europe.